Small cap news round-up
Creator and publisher of mobile real money and social games, Gaming Realms, announced on Friday that is has signed a marketing partnership deal with Bauer Media UK.
The AIM-traded firm said the three-year partnership and revenue share agreement with Bauer relates to Gaming Realms' Spin Genie real-money gaming website.
Noida Toll Bridge Company posted its results for the quarter ended 30 June on Friday.
The AIM-traded firm reported a profit before tax at INR 137.21m for the quarter, compared to INR 158.58m at the same time last year.
StratMin Global Resources noted on Friday that Bass Metals has notified the Australian Stock Exchange of the issuance of equity in relation to Bass' recent capital raise, and the initial equity settlement component due to StratMin for the acquisition of Graphmada Mauritius.
The AIM-traded company said it issued 75 million new Bass ordinary shares at a price of $0.01 per share as part of the consideration for the divestment of Graphmada Mauritius.
Tricor announced on Friday that it has entered into a conditional sale and purchase agreement with KGGD and Dunamis Mining, whereby KGGD will acquire the iron sand processing plant and equipment of Tricor Minerals, a 72% subsidiary of Tricor.
The AIM-traded firm said that In addition, Tricor Environmental - a wholly-owned subsidiary of the company - has entered into a new operating arrangement with KGGD.
EMIS’s revenues rose as it maintained that despite political and economic uncertainty, in light of the Brexit vote, it is encouraged by NHS investment.
The AIM-listed healthcare software provider said it was performing broadly in line with expectations for the first half of the year as market share and momentum in order books were maintained despite the uncertainty created by the EU referendum and slower than expected contract awards from the NHS.
For the six months ended 30 June, revenue increased slightly by 1% to £78.7m, compared to the same period last year.
Midatech Pharma’s half-year revenues increased significantly, with management sounding an optimistic note regarding the potential of the company´s research and development programmes.
For the six months ended 30 June, revenue increased significantly to £3.8m from £320,000 in the same period last year.
International provider of software specialising in analytics, 'big data' and the 'internet of things', Fusionex, announced on Friday that it has signed an agreement with Bursa Malaysia Berhad, Kuala Lumpur's Stock Exchange.
The AIM-traded firm said the agreement entails the exchange's adoption of Fusionex Analytics (GIANT) for the purposes of its ‘Enterprise Data Analytics’ initiative, which will elevate Bursa Malaysia towards being a data-driven organisation.
Human disease models pioneer hVIVO announced on Friday that its landmark asthma stratification initiative is now underway, with the first volunteer inoculated with human rhinovirus at hVIVO's London-based clinical research unit.
The AIM-traded firm said the hVIVO asthma stratification program will characterise asthma patients according to clinical and biomarker phenotypes following HRV challenge to discover a more effective way to differentiate subtypes of asthma patients - enabling the development of targeted therapies, disease biomarkers and more precision medicine-based approaches to asthma care.
Life science company Abcam is to pay the first performance-based payment of $5.2m for its acquisition of AmioMx through a share placing on AIM, the London Stock Exchange's junior market.
The Cambridge-based company bought AmioMx in November 2015 which included an agreement to make performance-based payments to the vendors over five years of about $25m.
Early-stage and pre-IPO disruptive technology investing company Vela Technologies was celebrating on Friday, noting an announcement released on 1 September by BTL Group.
The AIM-traded firm described BTL as a technology company based in Vancouver, Canada, focused on developing blockchain technologies to disrupt and transform existing industries.